KR102217942B1 - 과한 체중으로 영향 받은 여성 환자를 위한 드로스피레논-기반의 피임제 - Google Patents

과한 체중으로 영향 받은 여성 환자를 위한 드로스피레논-기반의 피임제 Download PDF

Info

Publication number
KR102217942B1
KR102217942B1 KR1020187001303A KR20187001303A KR102217942B1 KR 102217942 B1 KR102217942 B1 KR 102217942B1 KR 1020187001303 A KR1020187001303 A KR 1020187001303A KR 20187001303 A KR20187001303 A KR 20187001303A KR 102217942 B1 KR102217942 B1 KR 102217942B1
Authority
KR
South Korea
Prior art keywords
contraceptive
drsp
daily
active
drospirenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020187001303A
Other languages
English (en)
Korean (ko)
Other versions
KR20180019173A (ko
Inventor
도미니크 드루앵
세실 보이어-주버트
필립프 페린
Original Assignee
라보라토리오스 레온 파르마 에스에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56178376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102217942(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP15305965.4A external-priority patent/EP3108889A1/en
Priority claimed from CN201510348953.1A external-priority patent/CN106265694A/zh
Application filed by 라보라토리오스 레온 파르마 에스에이 filed Critical 라보라토리오스 레온 파르마 에스에이
Publication of KR20180019173A publication Critical patent/KR20180019173A/ko
Application granted granted Critical
Publication of KR102217942B1 publication Critical patent/KR102217942B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020187001303A 2015-06-23 2016-06-23 과한 체중으로 영향 받은 여성 환자를 위한 드로스피레논-기반의 피임제 Active KR102217942B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15305965.4A EP3108889A1 (en) 2015-06-23 2015-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight
EP15305965.4 2015-06-23
CN201510348953.1A CN106265694A (zh) 2015-06-23 2015-06-23 用于过重女性患者的基于屈螺酮的避孕药
CN201510348953.1 2015-06-23
PCT/EP2016/064574 WO2016207298A1 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Publications (2)

Publication Number Publication Date
KR20180019173A KR20180019173A (ko) 2018-02-23
KR102217942B1 true KR102217942B1 (ko) 2021-02-19

Family

ID=56178376

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187001303A Active KR102217942B1 (ko) 2015-06-23 2016-06-23 과한 체중으로 영향 받은 여성 환자를 위한 드로스피레논-기반의 피임제

Country Status (26)

Country Link
EP (1) EP3313408B1 (https=)
JP (1) JP6827962B2 (https=)
KR (1) KR102217942B1 (https=)
CN (2) CN113750108B (https=)
AU (1) AU2016282863B2 (https=)
BR (1) BR112017028048A2 (https=)
CA (1) CA2989975C (https=)
DK (1) DK3313408T3 (https=)
EA (1) EA036497B1 (https=)
ES (1) ES2970532T3 (https=)
FI (1) FI3313408T3 (https=)
HR (1) HRP20240121T8 (https=)
HU (1) HUE065350T2 (https=)
LT (1) LT3313408T (https=)
MX (1) MX389310B (https=)
MY (1) MY187233A (https=)
NI (1) NI201700173A (https=)
PH (1) PH12017502379A1 (https=)
PL (1) PL3313408T3 (https=)
RS (1) RS65196B1 (https=)
SI (1) SI3313408T1 (https=)
SM (1) SMT202400062T1 (https=)
SV (1) SV2017005602A (https=)
UA (1) UA122873C2 (https=)
WO (1) WO2016207298A1 (https=)
ZA (1) ZA201800067B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
DK3701944T3 (da) 2015-06-18 2022-03-14 Estetra Srl Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CR20180042A (es) 2015-06-18 2018-05-03 Mithra Pharmaceuticals S A Unidad de dosificación orodispersable que contiene un componente estetrol.
RS65196B1 (sr) 2015-06-23 2024-03-29 Laboratorios Leon Farma Sa Kontraceptivno sredstvo na bazi drospirenona za pacijentkinje sa viškom težine
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
CN111989105B (zh) 2018-04-19 2024-07-19 埃斯特拉私人有限责任公司 化合物以及它们在缓解绝经相关症状中的用途
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012000981A1 (en) * 2010-06-29 2012-01-05 Laboratorios Leon Farma Sa Pharmaceutical composition comprising drospirenone and contraceptive kit

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
WO2004041288A1 (en) * 2002-11-05 2004-05-21 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
GT200500099A (es) * 2004-04-30 2006-05-05 Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
WO2006014476A1 (en) * 2004-07-07 2006-02-09 Wyeth Cyclic progestin regimens and kits
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
DE502005004948D1 (de) 2005-07-21 2008-09-18 Bayer Schering Pharma Ag Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen
US20090023693A1 (en) * 2007-04-05 2009-01-22 Vladimir Hanes New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
WO2011113196A1 (zh) * 2010-03-16 2011-09-22 台州太法药业有限公司 屈螺酮制备方法
RU2422824C1 (ru) * 2010-05-07 2011-06-27 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
CN103372015A (zh) * 2012-04-19 2013-10-30 国家人口计生委科学技术研究所 包含屈螺酮或屈螺酮和雌激素的阴道环制剂
RU2527357C1 (ru) * 2013-08-02 2014-08-27 Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет
RS65196B1 (sr) 2015-06-23 2024-03-29 Laboratorios Leon Farma Sa Kontraceptivno sredstvo na bazi drospirenona za pacijentkinje sa viškom težine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012000981A1 (en) * 2010-06-29 2012-01-05 Laboratorios Leon Farma Sa Pharmaceutical composition comprising drospirenone and contraceptive kit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
American journal of obstetrics & Gynecology. vol. 201(3), 2009. 9.

Also Published As

Publication number Publication date
ZA201800067B (en) 2019-07-31
CA2989975A1 (en) 2016-12-29
EP3313408A1 (en) 2018-05-02
CN108025014A (zh) 2018-05-11
BR112017028048A2 (pt) 2018-09-04
EP3313408B1 (en) 2023-12-06
SI3313408T1 (sl) 2024-04-30
SMT202400062T1 (it) 2024-03-13
WO2016207298A1 (en) 2016-12-29
JP2018527305A (ja) 2018-09-20
RS65196B1 (sr) 2024-03-29
HRP20240121T8 (hr) 2024-05-10
HRP20240121T1 (hr) 2024-04-12
PL3313408T3 (pl) 2024-04-15
LT3313408T (lt) 2024-03-12
PH12017502379A1 (en) 2018-06-25
CN113750108B (zh) 2025-08-19
DK3313408T3 (da) 2024-01-29
ES2970532T3 (es) 2024-05-29
AU2016282863A1 (en) 2018-02-08
JP6827962B2 (ja) 2021-02-10
UA122873C2 (uk) 2021-01-13
SV2017005602A (es) 2018-08-14
NI201700173A (es) 2018-04-02
HK1255216A1 (zh) 2019-08-09
MY187233A (en) 2021-09-13
CA2989975C (en) 2021-10-12
FI3313408T3 (fi) 2024-01-25
EA201792595A1 (ru) 2018-06-29
AU2016282863B2 (en) 2021-05-27
NZ739195A (en) 2024-04-26
CN108025014B (zh) 2021-10-22
KR20180019173A (ko) 2018-02-23
MX2017016801A (es) 2018-05-11
HUE065350T2 (hu) 2024-05-28
CN113750108A (zh) 2021-12-07
MX389310B (es) 2025-03-20
EA036497B1 (ru) 2020-11-17

Similar Documents

Publication Publication Date Title
KR102217942B1 (ko) 과한 체중으로 영향 받은 여성 환자를 위한 드로스피레논-기반의 피임제
US11291633B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US11951213B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US10179140B2 (en) Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
KR20240047421A (ko) 자궁내막증 치료 및 효과적인 피임 제공 방법
EP3108889A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK40061928A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
KR102210982B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
HK40061928B (zh) 用於过重女性患者的基於屈螺酮的避孕药
OA18512A (en) Drospirenone-based contraceptive for a female patient affected with excess weight.
HK40080446A (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
AU2011273605B8 (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
HK1232778A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK1232778A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
CN106265694A (zh) 用于过重女性患者的基于屈螺酮的避孕药
HK40026911A (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
HK1255216B (zh) 用於过重女性患者的基於屈螺酮的避孕药

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20180115

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190308

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200518

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20201125

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20200518

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20201125

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20200717

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20190308

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20210107

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20201224

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20201125

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20200717

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20190308

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210215

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210215

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20240125

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20250123

Start annual number: 5

End annual number: 5